Carborundum Universal
Carborundum Universal
Industrial ProductsKey Fundamentals
SmallcapAbrasives & BearingsIndustrial ProductsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 27.2%
Weaknesses
1- Company has a low return on equity of 10.8% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
Carborundum Universal Ltd, a Murugappa Group company in the industrial abrasives and ceramics space, trades at a market cap of ₹20,208 Cr with an elevated P/E of 110.6x. While the company has delivered 10% compounded sales growth over the past decade, recent profitability has deteriorated with TTM profit declining 14%, and ROE has dropped from a 10-year average of 13% to 7% in the last year.
- Consistent long-term revenue compounder with 10% compounded sales CAGR over the past 10 years, demonstrating durable demand for its abrasives and ceramics portfolio
- TTM sales growth has reaccelerated to 10%, outpacing the 3-year compounded sales growth of 4%, suggesting a potential recovery in topline momentum
- 10-year stock CAGR of 15% reflects sustained long-term wealth creation for shareholders despite near-term weakness
- Healthy dividend payout ratio of 27.2% indicates disciplined capital allocation and commitment to returning cash to shareholders
- 5-year compounded sales growth of 15% is significantly higher than the 10-year average of 10%, pointing to an accelerating revenue base over the medium term
- 5-year average ROE of 12% and 10-year average ROE of 13% suggest the business has historically generated adequate returns on equity capital
- Part of the established Murugappa Group with a diversified product portfolio across electro-minerals, abrasives, and industrial ceramics — sectors tied to India's manufacturing and infrastructure buildout
- P/E ratio of 110.6x is extremely elevated for an industrial products company, implying the stock prices in aggressive growth that current earnings do not support
- TTM compounded profit has declined 14%, and 3-year compounded profit growth is also negative at -14%, signalling a sustained earnings deterioration
- Last year ROE has collapsed to 7% from the 5-year average of 12% and 10-year average of 13%, indicating a sharp decline in capital efficiency
- 3-year ROE of only 11% and a screener-flagged 3-year average ROE of 10.8% are low for a business commanding a P/B of 5.33x
- 5-year compounded profit growth of -3% shows the company has been unable to translate revenue growth into bottom-line expansion over a meaningful period
- 3-year stock CAGR of -3% indicates the market has already begun de-rating the stock amid weakening fundamentals
- Dividend yield of just 0.37% offers minimal income cushion despite the 27.2% payout ratio, reflecting the high valuation
- Wide divergence between 5-year sales CAGR of 15% and 5-year profit CAGR of -3% suggests margin compression or rising cost pressures eroding profitability
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Crisil ESG rating received Aug 25
Carborundum Universal disclosed an independent ESG rating assigned by Crisil ESG Ratings & Analytics, published on exchange websites on August 24, 2026, based on public domain information.
TL;DR: Limited news flow for Carborundum Universal with only an ESG rating disclosure from Crisil, which is a routine transparency event rather than a material catalyst. No headwinds or positive triggers are visible in the current batch. The outlook remains neutral pending quarterly results or sector-specific developments in the industrial products space.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,203 | 1,146 | 1,151 | 1,201 | 1,198 | 1,224 | 1,255 | 1,217 | 1,219 | 1,298 | 1,291 | 1,398 | 1,427 |
| Expenses | 1,034 | 979 | 960 | 992 | 1,004 | 1,029 | 1,078 | 1,071 | 1,098 | 1,142 | 1,134 | 1,254 | 1,292 |
| Operating Profit | 169 | 168 | 191 | 209 | 194 | 195 | 177 | 146 | 121 | 156 | 157 | 144 | 135 |
| OPM % | 14% | 15% | 17% | 17% | 16% | 16% | 14% | 12% | 10% | 12% | 12% | 10% | 9% |
| Other Income | 41 | 31 | 25 | 25 | 19 | 23 | -77 | 18 | 27 | 23 | 22 | -103 | 55 |
| Interest | 5 | 5 | 5 | 4 | 3 | 4 | 4 | 3 | 3 | 4 | 5 | 6 | 6 |
| Depreciation | 46 | 46 | 48 | 51 | 51 | 52 | 53 | 56 | 59 | 62 | 61 | 65 | 66 |
| PBT | 160 | 148 | 163 | 180 | 158 | 162 | 43 | 105 | 86 | 113 | 113 | -30 | 119 |
| Tax % | 26% | 30% | 31% | 21% | 27% | 28% | 13% | 71% | 30% | 34% | 35% | 34% | 33% |
| Net Profit | 118 | 104 | 112 | 143 | 115 | 116 | 38 | 30 | 60 | 74 | 73 | -40 | 80 |
| EPS in Rs | 5.96 | 5.36 | 5.86 | 7.09 | 5.94 | 6.09 | 1.83 | 1.53 | 3.25 | 3.91 | 3.99 | -0.92 | 4.01 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,042 | 1,944 | 2,112 | 2,374 | 2,689 | 2,599 | 2,632 | 3,325 | 4,654 | 4,702 | 4,894 | 5,206 | 5,414 |
| Expenses | 1,808 | 1,636 | 1,777 | 1,975 | 2,250 | 2,199 | 2,166 | 2,784 | 3,999 | 3,961 | 4,178 | 4,624 | 4,821 |
| Operating Profit | 234 | 308 | 336 | 400 | 439 | 400 | 466 | 540 | 655 | 741 | 717 | 582 | 593 |
| OPM % | 11% | 16% | 16% | 17% | 16% | 15% | 18% | 16% | 14% | 16% | 15% | 11% | 11% |
| Other Income | 112 | 39 | 41 | 37 | 46 | 62 | 32 | 56 | 136 | 118 | -23 | -35 | -3 |
| Interest | 25 | 23 | 18 | 9 | 8 | 6 | 4 | 6 | 24 | 18 | 14 | 19 | 21 |
| Depreciation | 100 | 87 | 96 | 106 | 108 | 105 | 99 | 115 | 187 | 191 | 212 | 247 | 253 |
| PBT | 220 | 237 | 262 | 322 | 369 | 351 | 395 | 477 | 580 | 650 | 468 | 282 | 315 |
| Tax % | 37% | 34% | 30% | 32% | 33% | 22% | 26% | 27% | 24% | 27% | 36% | 40% | — |
| Net Profit | 138 | 155 | 184 | 220 | 248 | 275 | 293 | 350 | 442 | 476 | 299 | 168 | 188 |
| EPS in Rs | 7.05 | 7.65 | 9.27 | 11.41 | 13.09 | 14.38 | 15 | 17.56 | 21.8 | 24.24 | 15.37 | 10.22 | 10.99 |
| Div. Payout % | 18% | 20% | 19% | 20% | 21% | 19% | 20% | 20% | 16% | 16% | 26% | 39% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
| Reserves | 1,070 | 1,173 | 1,364 | 1,545 | 1,705 | 1,839 | 2,113 | 2,345 | 2,802 | 3,107 | 3,510 | 3,881 |
| Borrowings | 340 | 320 | 156 | 129 | 97 | 70 | 62 | 240 | 277 | 172 | 216 | 413 |
| Other Liabilities | 387 | 348 | 374 | 394 | 401 | 354 | 486 | 692 | 774 | 793 | 835 | 959 |
| Total Liabilities | 1,816 | 1,860 | 1,913 | 2,088 | 2,222 | 2,283 | 2,679 | 3,296 | 3,872 | 4,091 | 4,580 | 5,271 |
| Fixed Assets | 793 | 659 | 705 | 736 | 695 | 748 | 777 | 1,006 | 1,527 | 1,555 | 1,716 | 1,906 |
| CWIP | 43 | 85 | 73 | 30 | 46 | 39 | 28 | 58 | 87 | 84 | 118 | 141 |
| Investments | 41 | 131 | 124 | 180 | 227 | 189 | 127 | 138 | 161 | 172 | 201 | 199 |
| Other Assets | 938 | 985 | 1,011 | 1,141 | 1,254 | 1,307 | 1,747 | 2,094 | 2,096 | 2,280 | 2,544 | 3,025 |
| Total Assets | 1,816 | 1,860 | 1,913 | 2,088 | 2,222 | 2,283 | 2,679 | 3,296 | 3,872 | 4,091 | 4,580 | 5,271 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 326 | 178 | 295 | 213 | 202 | 407 | 451 | 245 | 430 | 602 | 304 | 367 |
| Investing | -136 | -75 | -72 | -75 | -85 | -105 | -266 | -465 | -248 | -229 | -371 | -167 |
| Financing | -162 | -86 | -207 | -83 | -109 | -135 | -66 | 89 | -133 | -214 | -110 | 119 |
| Net Cash Flow | 28 | 17 | 16 | 55 | 7 | 168 | 119 | -131 | 49 | 159 | -177 | 320 |
| Free Cash Flow | 339 | 96 | 190 | 121 | 107 | 284 | 348 | -315 | 130 | 367 | 28 | 60 |
| CFO/OP | 169 | 85 | 111 | 81 | 73 | 127 | 119 | 70 | 90 | 109 | 70 | 93 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 69 | 66 | 73 | 70 | 56 | 66 | 53 | 49 | 53 | 57 | 62 |
| Inventory Days | 198 | 198 | 192 | 199 | 204 | 209 | 187 | 218 | 191 | 183 | 215 | 200 |
| Days Payable | 87 | 72 | 82 | 90 | 80 | 80 | 123 | 117 | 72 | 73 | 71 | 76 |
| Cash Conversion Cycle | 177 | 196 | 176 | 182 | 194 | 185 | 130 | 154 | 169 | 163 | 201 | 187 |
| Working Capital Days | 44 | 56 | 74 | 85 | 95 | 88 | 77 | 57 | 70 | 73 | 97 | 75 |
| ROCE % | 10% | 17% | 18% | 20% | 21% | 18% | 19% | 20% | 20% | 20% | 16% | 11% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Carborundum Universal insights
64 extracted metrics + investor summaries across FY11–FY26.
Documents
Frequently Asked Questions about Carborundum Universal
What does Carborundum Universal Ltd do?
Where is Carborundum Universal Ltd (CARBORUNIV) listed?
Which sector does Carborundum Universal Ltd belong to?
What is the market capitalisation of Carborundum Universal Ltd?
What is the PE ratio of Carborundum Universal Ltd?
What is the 52-week high and low of Carborundum Universal Ltd?
Does Carborundum Universal Ltd pay dividends?
What is the Return on Equity (ROE) of Carborundum Universal Ltd?
Company Information
Carborundum Universal Ltd, a part of the Chennai-based Murugappa group, is engaged in the manufacturing of abrasives, ceramics, refractories, and electro-minerals. [1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CARBORUNIV.md for Carborundum Universal Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.